Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Product Unit Size | Cost | Quantity | Stock |
|---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Cas No. | 1700693-08-8 |
|---|---|
| Purity | ≥98% |
| Formula | C19H21ClN6O3 |
| Formula Wt. | 416.87 |
| IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
| Synonym | Pyrrolopyrimidine |
| Solubility | DMSO |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
Metabolite of clofibrate; PPARα agonist.
A third-generation ALK inhibitor.
Adenosine analog
Nitroimidazole; hypoxic modifier and radiosensi...
Naphthodianthrone found in Hypericum; dopamine ...
NSAID; COX-1/2 inhibitor.
Peptide fragment of VSV; LDLR agonist.
Taxol synthesis intermediate.
Mycotoxin contaminant found in cereal grains.
Jumonji histone demethylase inhibitor.
Peptide; galanin antagonist.
Topoisomerase II inhibitor, RPA modulator.
Synthesis intermediate
Tetracycline; protein translation inhibitor, MM...
Peptide; GABA potentiator, NMDA negative allost...
Non-depolarizing NMJ blocker; nAChR antagonist....
PAK inhibitor.Smo inhibitor.
Promotes degradation of cIAP1
Alkaloid originally found in species of Nicotia...
SIRT1/2 inhibitor, indirect p53 activator.